Study guide

6.4 Acute Kidney Injury & Renal Replacement Therapies

ANCC Medical-Surgical Nursing Certification MEDSURG-BC

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts: Format, Scoring, Cost 1.2 Eligibility, Application & Scheduling 1.3 Blueprint Breakdown & Study Strategy 1.4 Test-Taking Strategies for ANCC Scenario Items

2 Assessment Skills

2.1 Health History Collection 2.2 Physical Assessment 2.3 Psychosocial Assessment 2.4 Cognitive & Neurological Screening

3 Diagnostics & Clinical Reasoning

3.1 Diagnostic & Laboratory Testing 3.2 Fluids & Electrolytes 3.3 Nursing Diagnosis Identification & Prioritization

4 Cardiovascular & Hematologic

4.1 Cardiovascular Assessment & Diagnostics 4.2 Cardiovascular Disorders & Management 4.3 Hematologic Disorders & Blood Products

5 Respiratory

5.1 Respiratory Assessment & Diagnostics 5.2 Respiratory Disorders & Management 5.3 Oxygen Therapy & Ventilation Support

6 Gastrointestinal & Renal

6.1 GI Assessment & Common Disorders 6.2 GI Management & Nutrition Support 6.3 Renal & Urinary Assessment & Disorders 6.4 Acute Kidney Injury & Renal Replacement Therapies

7 Neurologic & Musculoskeletal

7.1 Neurologic Assessment & Stroke 7.2 Neurologic Disorders & Management 7.3 Musculoskeletal Assessment & Disorders 7.4 Orthopedic Care, Immobilization & Mobility

8 Endocrine, Integumentary & Immune

8.1 Endocrine Assessment & Diabetes Management 8.2 Thyroid, Adrenal & Metabolic Disorders 8.3 Integumentary Disorders & Wound Care 8.4 Immune, Infectious & Multisystem Conditions

9 Care Planning & Education

9.1 Nursing Care Planning 9.2 Patient Teaching: Process & Evaluation 9.3 Education Topics & Self-Management 9.4 Health & Wellness Promotion

10 Perioperative Care

10.1 Preoperative & Intraoperative Care 10.2 Postoperative Complication Prevention 10.3 Postoperative Emergencies: Bleeding, Infection, Emboli

11 Patient Safety

11.1 Patient Safety: Falls, Restraints & Equipment 11.2 Infection Prevention & Isolation Precautions 11.3 Recognizing Deterioration & Escalation of Care

12 Pharmacology

12.1 Safe Medication Administration 12.2 Interactions & Adverse Effects 12.3 Pain Management & Analgesics 12.4 Polypharmacy & High-Alert Medications

13 Non-Pharmacologic & Comfort Care

13.1 Non-Pharmacologic Treatments & CAM 13.2 Comfort & End-of-Life Care

14 Therapeutic Communication

14.1 Therapeutic Communication 14.2 Cultural Competence & Family-Centered Care 14.3 Difficult Conversations & Counseling

15 Interprofessional Collaboration

15.1 Interdisciplinary Team Collaboration 15.2 Delegation & Supervision 15.3 Care Coordination, Consults & Transitions

16 Ethics & Evidence-Based Practice

16.1 Nursing Ethics & Patient Advocacy 16.2 Legal & Regulatory Foundations 16.3 Evidence-Based Practice & Research 16.4 Quality Improvement & Safety Culture

6.4 Acute Kidney Injury & Renal Replacement Therapies

Key Takeaways Explain This Topic AI

Prerenal AKI (hypoperfusion) typically shows a BUN-to-creatinine ratio above 20:1; intrarenal AKI (such as acute tubular necrosis) shows muddy brown casts; postrenal AKI is caused by obstruction and is often reversible

Hyperkalemia is the most life-threatening electrolyte emergency in kidney failure — peaked T waves on ECG — treated first with IV calcium gluconate to stabilize the cardiac membrane, then insulin with dextrose

CKD is staged by GFR: stage 1 is 90 or greater and stage 5 (kidney failure) is below 15 mL/min/1.73 m2; complications include anemia, renal osteodystrophy, hyperkalemia, and fluid overload

Never take blood pressure, draw blood, or start an IV in the arm with an AV fistula or graft; assess patency every shift by palpating a thrill and auscultating a bruit

Cloudy peritoneal dialysis effluent with fever and abdominal pain means peritonitis — obtain an effluent culture and anticipate intraperitoneal antibiotics; dialysis indications are remembered by AEIOU

Last updated: August 2026

Acute Kidney Injury: Causes and Phases

Acute kidney injury (AKI) is an abrupt decline in kidney function, classified by location of the cause:

Prerenal (about 55%): anything that decreases renal perfusion — hypovolemia, heart failure, sepsis, hypotension. The kidneys themselves are healthy; labs show a BUN-to-creatinine ratio above 20:1 , low urine sodium, and concentrated urine. It reverses if perfusion is restored quickly.

Intrarenal: direct parenchymal damage — acute tubular necrosis (ATN) from prolonged ischemia or nephrotoxins (aminoglycosides, amphotericin B, iodinated contrast, rhabdomyolysis pigments), plus glomerulonephritis and interstitial nephritis. Muddy brown granular casts on urinalysis point to ATN.

Postrenal: obstruction of urine flow — benign prostatic hyperplasia, bilateral stones, strictures, tumors. A bladder scan and renal ultrasound identify it; relieving the obstruction (catheter, stent, nephrostomy) often restores function.

AKI classically moves through four phases. The onset (initiating) phase spans the insult until oliguria begins. The oliguric phase (urine output under 400 mL/day, lasting roughly 1 to 2 weeks) carries the highest mortality: expect hyperkalemia , fluid overload with hypertension and pulmonary edema, metabolic acidosis, and rising BUN and creatinine. The diuretic phase brings recovering tubular function with output of 1 to 3 liters (sometimes up to 5 liters) per day — the risk flips to dehydration, hypotension, and hypokalemia . The recovery (convalescent) phase may last up to a year, and some patients never regain full function.

Hyperkalemia (potassium above 5.0 mEq/L) is the most dangerous complication. Watch for peaked T waves, widened QRS, and prolonged PR interval on the ECG, plus muscle weakness. Treatment sequence: IV calcium gluconate first to stabilize the cardiac membrane (it does not lower potassium), then IV regular insulin with dextrose to shift potassium into cells, plus adjuncts such as nebulized albuterol and sodium bicarbonate when significant metabolic acidosis is present; loop diuresis when appropriate, selected potassium binders, and dialysis remove potassium from the body.

Chronic Kidney Disease: Stages and Complications

Chronic kidney disease (CKD) is irreversible, progressive loss of function staged by glomerular filtration rate (GFR):

  • Stage GFR (mL/min/1.73 m2) Description
  • G1 90 or greater Normal function with evidence of kidney damage
  • G2 60 to 89 Mild decrease
  • G3a / G3b 45 to 59 / 30 to 44 Moderate decrease
  • G4 15 to 29 Severe decrease
  • G5 Below 15 Kidney failure — renal replacement usually needed

Leading causes are diabetes and hypertension. Complications and their management:

Anemia: failing kidneys produce less erythropoietin . Treat with erythropoiesis-stimulating agents (epoetin alfa) plus iron; current targets hold hemoglobin around 10 to 11.5 g/dL — full normalization increases cardiovascular risk.

Renal osteodystrophy (CKD-MBD): the failing kidney retains phosphate and activates less vitamin D, so calcium falls and parathyroid hormone rises ( secondary hyperparathyroidism ), leaching calcium from bone. Give phosphate binders (calcium acetate, sevelamer) with meals , restrict dietary phosphorus, and use active vitamin D analogs.

Hyperkalemia: restrict dietary potassium and avoid salt substitutes (potassium chloride).

Fluid overload and hypertension: sodium and fluid restriction plus diuretics; cardiovascular disease is the leading cause of death in CKD.

Uremic symptoms: nausea, pruritus, fatigue, pericarditis (friction rub), and encephalopathy signal the need for dialysis.

Diet teaching: limit sodium, potassium, and phosphorus; protein is moderated before dialysis (about 0.6 to 0.8 g/kg/day) but increased on dialysis (about 1.2 g/kg/day) to replace dialytic losses.

Hemodialysis and Vascular Access

Hemodialysis circulates blood through a dialyzer to remove solutes and fluid, typically three times weekly. Access options, in order of preference: arteriovenous (AV) fistula (best long-term patency, lowest infection risk — needs weeks to months to mature), AV graft , and tunneled central catheter (highest infection risk, last resort).

Access protection rules are heavily tested:

Never take blood pressure, draw blood, or insert an IV in the access arm. Post signs and teach the patient.

Palpate a thrill and auscultate a bruit every shift — their absence suggests thrombosis; notify the provider immediately.

No tight clothing, jewelry, or restraints on the access arm; teach the patient to check the thrill daily and avoid sleeping on that arm.

After dialysis, hold pressure on needle sites and assess for bleeding.

Intradialytic complications: hypotension is most common (rapid fluid removal — pause ultrafiltration, give a saline bolus per protocol, lower the head of the bed), muscle cramps, and dialysis disequilibrium syndrome (rapid solute shifts cause cerebral edema — headache, nausea, confusion; more common in new patients with very high BUN). Weigh the patient before and after treatment, and check whether antihypertensives should be held before dialysis.

Peritoneal Dialysis

Peritoneal dialysis (PD) uses the patient's peritoneum as the membrane: dialysate is instilled, dwells, and drains out as effluent , which should be clear and pale yellow . Cloudy effluent with fever, abdominal pain, and rebound tenderness signals peritonitis — the most common PD complication. Obtain a culture of the effluent , notify the provider, and anticipate antibiotics, often instilled into the dialysate; do not stop exchanges unless ordered.

Other essentials: use strict aseptic technique with a mask during exchanges, warm the dialysate (never in a microwave — use a warming device per facility), and compare outflow to inflow — retained fluid suggests outflow obstruction from constipation, catheter migration, or fibrin; repositioning and bowel regimens help. Monitor glucose because dextrose-based dialysate is absorbed, and check blood pressure and weight trends.

Indications for Dialysis: AEIOU

Emergent dialysis indications are remembered with the mnemonic AEIOU :

A — Acidosis: severe metabolic acidosis refractory to medical management.

E — Electrolytes: refractory hyperkalemia (especially with ECG changes).

I — Ingestions/Intoxications: dialyzable toxins such as lithium, salicylates, methanol, ethylene glycol, and metformin-associated lactic acidosis.

O — Overload: fluid overload with pulmonary edema unresponsive to diuretics.

U — Uremia: symptomatic uremia — pericarditis, encephalopathy, uremic bleeding, intractable nausea.

Post-Transplant Basics

Kidney transplantation requires lifelong immunosuppression — typically a calcineurin inhibitor ( tacrolimus or cyclosporine; monitor trough levels — both are nephrotoxic at high levels), an antiproliferative (mycophenolate), and corticosteroids. Teach that missing doses invites rejection . Rejection signs include fever, pain or tenderness over the graft, rising creatinine, decreasing urine output, weight gain, and flu-like symptoms — report immediately, because early treatment can save the graft. Infection risk is high: avoid live vaccines, practice meticulous hygiene, and avoid grapefruit, which raises calcineurin inhibitor levels.

Nephrotoxic Drug Awareness

Protect remaining renal function by recognizing nephrotoxins:

NSAIDs — reduce renal perfusion via prostaglandin inhibition; avoid in CKD and AKI.

Aminoglycosides (gentamicin) and vancomycin — dose by renal function and monitor trough levels.

Amphotericin B — classic tubular toxin.

Iodinated contrast — assess renal risk and use current contrast protocol. Metformin is not routinely held for IV contrast when there is no AKI and eGFR is at least 30; higher-risk patients require a hold and 48-hour reassessment.

ACE inhibitors/ARBs — helpful long-term for proteinuria but can worsen function during hypoperfusion and raise potassium.

Always check renal function before administering these agents, ensure adequate hydration, and question nephrotoxic orders in patients with rising creatinine.